Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.71−0.32 (-7.94%)
Close on Nov 13, 2026Market cap $154.33MP/E 1.1Yield 6.74%
Oramed Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Oramed Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2025 was 3202.5%. For fiscal 2025 it was 3202.5%, against 379.7% the year before. The highest annual figure on record is 3202.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3202.5% | +2822.8 |
| FY2023 | Dec 31, 2023 | 379.7% | +1230.2 |
| FY2021 | Aug 31, 2021 | -850.5% | −425.7 |
| FY2020 | Aug 31, 2020 | -424.8% | +106.3 |
| FY2019 | Aug 31, 2019 | -531.1% | −11.4 |
| FY2018 | Aug 31, 2018 | -519.7% | −93.0 |
| FY2017 | Aug 31, 2017 | -426.7% | +1283.7 |
| FY2016 | Aug 31, 2016 | -1710.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -382.1% | +382.5 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -177.2% | +515.8 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -509.8% | +316.6 |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -1113.3% | −673.4 |
| Q3 FY2021CQ2 2021 | May 31, 2021 | -764.6% | −429.2 |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | -692.9% | −145.8 |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | -826.4% | −449.1 |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | -439.9% | +3441.1 |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -335.4% | −932.5 |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -547.2% | −73.0 |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -377.3% | +328.4 |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -3881.1% | −3398.3 |
| Q3 FY2019CQ2 2019 | May 31, 2019 | 597.1% | +1011.3 |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -474.2% | −38.0 |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -705.7% | −387.2 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -482.8% | +38.2 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -414.2% | +17.9 |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -436.2% | +1411.8 |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -318.5% | +1135.9 |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -520.9% | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -432.1% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -1848.0% | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | -1454.4% | – |
See a number that looks wrong?